These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30543718)

  • 1. Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Fidalgo-Lopez J; Fournet G; Joseph B; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(12):e0209522. PubMed ID: 30543718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: The New Face of the Old Molecules: Crustin Pm4 and Transglutaminase Type I Serving as RNPs Down-Regulate Astakine-Mediated Hematopoiesis.
    Chang YT; Lin CY; Tsai CY; Siva VS; Chu CY; Tsai HJ; Song YL
    PLoS One; 2017; 12(7):e0182405. PubMed ID: 28750060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    Azami M; YektaKooshali MH; Shohani M; Khorshidi A; Mahmudi L
    PLoS One; 2019; 14(7):e0219466. PubMed ID: 31287842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
    Amato MP; Prestipino E; Bellinvia A; Niccolai C; Razzolini L; Pastò L; Fratangelo R; Tudisco L; Fonderico M; Mattiolo PL; Goretti B; Zimatore GB; Losignore NA; Portaccio E; Lolli F
    PLoS One; 2019; 14(11):e0225494. PubMed ID: 31725815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    Nociti V; Santoro M; Quaranta D; Losavio FA; De Fino C; Giordano R; Palomba NP; Rossini PM; Guerini FR; Clerici M; Caputo D; Mirabella M
    PLoS One; 2019; 14(2):e0212906. PubMed ID: 30789956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    Charvet LE; Yang J; Shaw MT; Sherman K; Haider L; Xu J; Krupp LB
    PLoS One; 2018; 13(1):e0192317. PubMed ID: 29381774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLOS ONE Staff
    PLoS One; 2018; 13(5):e0196928. PubMed ID: 29715325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression.
    Romme Christensen J; Börnsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    PLoS One; 2013; 8(3):. PubMed ID: 29294474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Effects of Porphyromonas gingivalis LipopolysaccharideTolerized Monocytes on Inflammatory Responses in Neutrophils.
    PLOS ONE Staff
    PLoS One; 2016; 11(10):e0165568. PubMed ID: 27768765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Exposure to 1.8 GHz electromagnetic fields affects morphology, DNA-related Raman spectra and mitochondrial functions in human lympho-monocytes.
    Lasalvia M; Scrima R; Perna G; Piccoli C; Capitanio N; Biagi PF; Schiavulli L; Ligonzo T; Centra M; Casamassima G; Ermini A; Capozzi V
    PLoS One; 2018; 13(6):e0198892. PubMed ID: 29879212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases.
    PLOS ONE staff
    PLoS One; 2018; 13(2):e0192875. PubMed ID: 29420630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
    Vera B; Martínez-Vélez N; Xipell E; Acanda de la Rocha A; Patiño-García A; Castresana JS; Gonzalez-Huarriz M; Cascallo M; Alemany R; Alonso MM
    PLoS One; 2016; 11(6):e0157619. PubMed ID: 27280773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Characterization of an intratracheal aerosol challenge model of Brucella melitensis in guinea pigs.
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Samuel J; Arenas-Gamboa AM
    PLoS One; 2019; 14(6):e0218065. PubMed ID: 31185039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
    Fusco R; Gugliandolo E; Campolo M; Evangelista M; Di Paola R; Cuzzocrea S
    PLoS One; 2018; 13(7):e0201501. PubMed ID: 30044864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Monoallelic Germline TSC1 Mutations Are Permissive for T Lymphocyte Development and Homeostasis in Tuberous Sclerosis Complex Individuals.
    Pilipow K; Basso V; Migone N; Mondino A
    PLoS One; 2019; 14(6):e0218354. PubMed ID: 31173608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: TWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity.
    PLOS ONE Staff
    PLoS One; 2018; 13(2):e0192816. PubMed ID: 29420614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S; Spini M; Hua J; Harrison DM
    PLoS One; 2022; 17(2):e0264452. PubMed ID: 35192677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.
    Eitas TK; Stepp WH; Sjeklocha L; Long CV; Riley C; Callahan J; Sanchez Y; Gough P; Knowlin L; van Duin D; Ortiz-Pujols S; Jones SW; Maile R; Hong Z; Berger S; Cairns BA
    PLoS One; 2017; 12(11):e0187785. PubMed ID: 29095909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
    Selby MJ; Engelhardt JJ; Johnston RJ; Lu LS; Han M; Thudium K; Yao D; Quigley M; Valle J; Wang C; Chen B; Cardarelli PM; Blanset D; Korman AJ
    PLoS One; 2016; 11(11):e0167251. PubMed ID: 27861630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
    Davis EM; Baust JJ; O'Donnell BJ; Shah FA; McDowell A; Guo L; O'Donnell CP
    PLoS One; 2019; 14(6):e0218401. PubMed ID: 31181114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.